Charles “Charlie” Juxon Welsh, the co-founder of financial news provider Mergermarket, died on May 16th, 2021. Charles was born on December 1st, 1965 in London, England to Geoffrey and Anne (Bury) Welsh and grew up with his parents and three siblings in Ottawa, Canada.
The accomplished business and finance editorial specialist graduated from the London School of Economics and Political Science (LSE) in 1992 with a B.A. in International History and continued his studies at Columbia’s School of International and Public Affairs (SIPA) with an MIA, International Political Economy in 1994. In 1996, he enlisted in the Army Reserve Force for the British Army, just two months shy of the 32-year-old enlistment cut-off age.
In 1999, Charles co-founded The Mergermarket Group, which became a highly influential global publisher of business and capital markets intelligence. The company was sold to The Financial Times Group in 2006 and has continued to grow under various owners.
He was known for his extraordinary work ethic, his focus on his entrepreneurial ventures, his strong opinions, and his inspiring and passionate presence in the newsroom. Charles always encouraged young people to have opinions, too. “Have something to say for yourself,” he would say.
He was a devoted father to his four children and actively participated in their activities such as baseball, horseback riding, piano lessons, and their education. Charles took great enjoyment from cycling in the greater New York area, watching sports and walking his dog near his residence on the Upper West Side.
He will be dearly missed by his wife Emmanuelle (Petillon), his daughter Rozenn (29) and sons Thomas (24), Hugo (18) and Leonard (17), siblings James (Alison), Zoe and Alex (Heather), and his parents Anne and Geoffrey, as well as his friends across the globe. All are incredibly proud of his achievements and glad to have known him and will carry him in their hearts.
In lieu of flowers, the family requests donations be made in Charles’ memory to the National Pediatric Cancer Foundation.